Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Intrathecal immune reset in multiple sclerosis: Exploring a new concept.
A longitudinal model for disease progression was developed and applied to multiple sclerosis.
Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process.
Tamoxifen administration immediately or 24 hours after spinal cord injury improves locomotor recovery and reduces secondary damage in female rats.
Multiple sclerosis: Daclizumab HYP shows efficacy in patients with relapsing-remitting MS.
MicroRNAs and multiple sclerosis: from physiopathology toward therapy.
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
Long-term safety of azathioprine therapy in multiple sclerosis.
microRNAs: A connection between cholesterol metabolism and neurodegeneration.
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
Multiple sclerosis: Quadrivalent HPV vaccination does not increase risk of MS.
Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
Selectins and their ligands as potential immunotherapeutic targets in neurological diseases.
Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury.
Oncostatin M protects against demyelination by inducing a protective microglial phenotype.
Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays.
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria.
Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.
Primary Position Upbeat Nystagmus during an Acute Attack of Multiple Sclerosis.
The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis.
Pages
« first
‹ previous
…
521
522
523
524
525
526
527
528
529
…
next ›
last »